About Synpromics
Synpromics is a company based in Edinburgh (United Kingdom) founded in 2010 was acquired by AskBio in August 2019.. Synpromics has raised $9.86 million across 3 funding rounds from investors including AskBio, Scottish Enterprise and Calculus Capital. The company has 46 employees as of December 31, 2021. Synpromics operates in a competitive market with competitors including Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 46 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synpromics Ltd
- Date of Incorporation 27 Aug, 2010
- Jurisdiction MIDLOTHIAN, SCOTLAND
-
Annual Revenue
$125.77 K (USD)-94as on Dec 31, 2020
-
Net Profit
$-4.83 M (USD)-119as on Dec 31, 2020
-
EBITDA
-
Total Equity Funding
$9.86 M (USD)
in 3 rounds
-
Latest Funding Round
$2.43 M (USD), Grant
Jun 01, 2018
-
Investors
AskBio
& 2 more
-
Employee Count
46
as on Dec 31, 2021
-
Acquired by
AskBio
(Aug 13, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Synpromics
Synpromics has successfully raised a total of $9.86M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.43 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $2.4M
-
First Round
First Round
(14 Aug 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Grant - Synpromics | Valuation |
investors |
|
| Apr, 2017 | Amount | Series B - Synpromics | Valuation |
investors |
|
| Aug, 2015 | Amount | Series A - Synpromics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synpromics
Synpromics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include AskBio, Scottish Enterprise and Calculus Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UK venture capital investments are managed by Calculus Capital.
|
Founded Year | Domain | Location | |
|
Business development and leadership training programs are offered to companies.
|
Founded Year | Domain | Location | |
|
Gene and protein therapies are developed for treating various diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synpromics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Synpromics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synpromics Comparisons
Competitors of Synpromics
Synpromics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, Avidity Biosciences, AskBio and Univercells, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synpromics
Frequently Asked Questions about Synpromics
When was Synpromics founded?
Synpromics was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Where is Synpromics located?
Synpromics is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Is Synpromics a funded company?
Synpromics is a funded company, having raised a total of $9.86M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.28M, raised on Aug 14, 2015.
How many employees does Synpromics have?
As of Dec 31, 2021, the latest employee count at Synpromics is 46.
What is the annual revenue of Synpromics?
Annual revenue of Synpromics is $125.77K as on Dec 31, 2020.
What does Synpromics do?
Synpromics was founded in 2010 in Edinburgh, United Kingdom, within the biotechnology sector. Synthetic promoters are developed to enable precise gene expression control. These are screened through a platform to build a library optimized for the CHO system. Applications include cell and gene therapy, biologics bioprocessing, industrial biotechnology, agricultural biotechnology, and cell-based assays. Operations focus on patentable designs for targeted regulatory solutions.
Who are the top competitors of Synpromics?
Synpromics's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.
Who are Synpromics's investors?
Synpromics has 3 investors. Key investors include AskBio, Scottish Enterprise, and Calculus Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.